Skip to content

13F-HR filed by BRAIDWELL LP

BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 81 holding rows worth $3,060,428,640.

Accession
0001420506-23-001695
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 82 entries on the cover page, a total value of $3,060,428,640 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,060,428,640 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC40131MAB5NOTE 11/1268,252,000$193,131,609dollars as filedprincipal
EXACT SCIENCES CORP30063PAC9NOTE 0.375% 3/0131,000,000$134,691,036dollars as filedprincipal
NOVOCURE LTD67011XAB9NOTE 11/0135,834,000$118,179,303dollars as filedprincipal
NANOSTRING TECHNOLOGIES INC63009RAD1BOND145,520,000$115,400,772dollars as filedprincipal
Ascendis Pharma A/S04351PAD3Convertible bond124,000,000$113,150,000dollars as filedprincipal
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/1128,338,000$101,094,132dollars as filedprincipal
NEVRO CORP64157FAC7NOTE 2.750% 4/0109,251,000$100,947,924dollars as filedprincipal
NEUROCRINE BIOSCIENCES INC64125C109COM933,362$88,016,037dollars as filed
VAXCYTE INC COM92243G108Stock1,722,353$86,014,309dollars as filed
ALPHATEC HLDGS INC02081GAB8NOTE 0.750% 8/070,750,000$82,406,723dollars as filedprincipal
ALIGN TECHNOLOGY INC COM016255101Stock224,030$79,225,969dollars as filed
GLAUKOS CORP COM377322102Stock1,044,392$74,371,154dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock1,828,353$70,391,591dollars as filed
NATERA INC COM632307104Stock1,152,851$56,097,730dollars as filed
DECIPHERA PHARMACEUTICALS IN24344T101COM3,646,419$51,341,580dollars as filed
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/156,031,000$50,500,740dollars as filedprincipal
NUVASIVE INC670704AJ4NOTE 0.375% 3/155,323,000$50,067,315dollars as filedprincipal
IONIS PHARMACEUTICALS INC462222AD2NOTE 4/052,740,000$50,004,113dollars as filedprincipal
IRHYTHM HOLDINGS INC COM450056106Stock478,557$49,923,066dollars as filed
DICE THERAPEUTICS INC23345J104COM1,029,901$47,849,200dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock1,143,865$45,960,496dollars as filed
NEVRO CORP64157F103COM1,776,368$45,155,275dollars as filed
KARYOPHARM THERAPEUTICS INC48576UAA4BOND65,976,000$43,016,352dollars as filedprincipal
Intuitive Surgical,Inc.46120E602COM123,820$42,339,011dollars as filed
MERUS N VN5749R100COM1,543,162$40,631,455dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock3,361,813$40,140,047dollars as filed
Boston Scientific Corporation101137107COM717,050$38,785,235dollars as filed
Bridgebio Pharma Inc Note 2.250 percent 2/010806XAD4Convertible62,294,000$38,552,328dollars as filedprincipal
LEGEND BIOTECH CORP52490G102SPONSORED ADS556,301$38,401,458dollars as filed
INSMED INC457669AA7NOTE 1.750% 1/139,963,000$38,004,813dollars as filedprincipal
PARAGON 28 INC69913P105COM2,136,122$37,894,804dollars as filed
NEOGENOMICS INC64049MAB6NOTE 0.250% 1/148,678,000$36,082,568dollars as filedprincipal
BIOGEN INC COM09062X103Stock121,942$34,735,179dollars as filed
ORTHOPEDIATRICS CORP68752L100COMMON STOCK761,208$33,378,971dollars as filed
OUTSET MEDICAL INC690145107COM1,460,368$31,938,248dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock2,901,194$30,085,382dollars as filed
AXONICS INC05465P101COM573,791$28,959,232dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,206,300$28,697,877dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock241,399$28,340,242dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR468,027$28,062,899dollars as filed
HARROW INC415858109COM1,452,538$27,656,324dollars as filed
NEOGENOMICS INC64049MAA8Convertible Debt28,000,000$26,302,500dollars as filedprincipal
AMYRIS INC03236MAJ0BOND137,850,000$26,191,500dollars as filedprincipal
ALECTOR INC014442107COMMON STOCK4,131,315$24,829,203dollars as filed
ANAPTYSBIO INC032724106COM1,154,423$23,480,964dollars as filed
DBV TECHNOLOGIES S A23306J101ADR12,107,785$23,004,792dollars as filed
TRAVERE THERAPEUTICS INC89422GAA5CNV28,350,000$22,804,031dollars as filedprincipal
PENUMBRA INC COM70975L107Stock65,844$22,654,287dollars as filed
ILLUMINA INC452327AK5NOTE 8/122,645,000$22,599,467dollars as filedprincipal
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK1,804,700$22,432,421dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM1,038,310$22,219,834dollars as filed
HILLEVAX INC43157M102COM1,249,246$21,474,539dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,908,865$20,539,387dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,791,880$19,654,835dollars as filed
COMPASS THERAPEUTICS INC20454B104COM5,954,273$18,934,588dollars as filed
RAPT THERAPEUTICS INC75382E109COM984,400$18,408,280dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM728,549$17,871,307dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock1,842,352$16,120,580dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock1,377,872$15,501,060dollars as filed
INVITAE CORP46185LAB9NOTE 2.000% 9/016,781,000$14,968,713dollars as filedprincipal
Thermo Fisher Scientific Inc.883556102COM27,300$14,243,775dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM843,087$13,902,505dollars as filed
INTEGRA LIFESCIENCES HLDGS C457985AM1NOTE 0.500% 8/114,500,000$13,311,000dollars as filedprincipal
Danaher Corporation235851102COM55,400$13,296,000dollars as filed
PULMONX CORP745848101COM999,362$13,101,636dollars as filed
REPLIGEN CORP COM759916109Stock92,000$13,014,320dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock650,312$11,718,622dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK487,520$11,320,214dollars as filed
ACELYRIN INC00445A100COM500,000$10,450,000dollars as filed
GUARDANT HEALTH INC COM40131M109Stock270,000$9,666,000dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK1,249,900$9,386,749dollars as filed
MINERALYS THERAPEUTICS INC603170101COM550,300$9,382,615dollars as filed
MIRATI THERAPEUTICS INC60468T105COM240,625$8,693,781dollars as filed
SEAGEN INC81181C104COM42,497$8,178,973dollars as filed
AGENUS INC00847G705COM NEW4,697,930$7,516,688dollars as filed
NUVATION BIO INC COM CL A67080N101Stock4,122,900$7,421,220dollars as filed
CUTERA INC232109AD0NOTE 2.250% 6/011,500,000$7,202,906dollars as filedprincipal
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock648,451$4,351,106dollars as filed
INSMED INC457669AB5NOTE 0.750% 6/03,500,000$2,953,125dollars as filedprincipal
ESPERION THERAPEUTICS INC NEW COM29664W105Stock895,949$1,245,369dollars as filed
ALPHATEC HLDGS INC02081G201COM NEW25,431$457,249dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-23-001695this filing2023-08-14acceptance time not in the bulk data set